Stuart Walter Peltz
CHIEF EXECUTIVE OFFICER at PTC Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: PTC Therapeutics Inc., 3 years.
PTC Therapeutics Inc.
Director · CHIEF EXECUTIVE OFFICER
Chief executive roles
PTC Therapeutics Inc.
· CHIEF EXECUTIVE OFFICER
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jan 31, 2023 | PTC Therapeutics Inc. | Open-market sale | −2,320 | $45.63 | $105,862 |
| Jan 31, 2023 | PTC Therapeutics Inc. | Open-market sale | −301 | $45.63 | $13,735 |
| Jan 24, 2023 | PTC Therapeutics Inc. | Open-market sale | −284 | $47.45 | $13,476 |
| Jan 11, 2023 | PTC Therapeutics Inc. | Open-market sale | −1,189 | $44.36 | $52,744 |
| Jan 11, 2023 | PTC Therapeutics Inc. | Open-market sale | −492 | $44.36 | $21,825 |
| Jan 10, 2023 | PTC Therapeutics Inc. | Open-market sale | −1,228 | $42.93 | $52,718 |
| Jan 10, 2023 | PTC Therapeutics Inc. | Open-market sale | −571 | $42.93 | $24,513 |
| Jan 9, 2023 | PTC Therapeutics Inc. | Open-market sale | −1,786 | $41.66 | $74,405 |
| Jan 9, 2023 | PTC Therapeutics Inc. | Open-market sale | −279 | $41.66 | $11,623 |
| Jan 5, 2023 | PTC Therapeutics Inc. | Grant or award | +53,000 | — | — |
| Jan 5, 2023 | PTC Therapeutics Inc. | Grant or award | +18,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.